Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries

Acta Tropica

Volumn 117, Issue 2, 2011, Pages 69-75

  Lu, Feng ^a,b   Lim, Chae Seung ^c   Nam, Deok Hwas ^c   Kim, Kwonkee ^d   Lin, Khin ^e   Kim, Tong Soo ^f   Lee, Hyeong Woo ^g,h   Chen, Jun Hu ^a,i   Wang, Yue ^a,i   Sattabongkot, Jetsumon ^j   Han, Eun Taek ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^c Korea University College of Medicine   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e DEPARTMENT OF HEALTH   (Myanmar)

^f Inha University School of Medicine   (South Korea)

^g Korea Centers for Disease Control and Prevention   (South Korea)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ INSTITUTE OF MATERIA MEDICA   (China)

^j ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

more..

Author keywords

Copy number; Drug resistance gene; In vitro drug susceptibility; Plasmodium vivax; Pvcrt o; Pvmdr1; Single nucleotide polymorphisms (SNPs)

Indexed keywords

ARTESUNATE; CHLOROQUINE; MEFLOQUINE; QUININE;

DISEASE TREATMENT; DRUG RESISTANCE; GENETIC ANALYSIS; INFECTIOUS DISEASE; MALARIA; MUTATION; POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; ENDEMIC DISEASE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; IC 50; IN VITRO STUDY; MYANMAR; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPUA NEW GUINEA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; PVCRT O GENE; PVMDR1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; THAILAND;

ANIMALS; ANTIMALARIALS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, VIVAX; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PAPUA NEW GUINEA; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; REPUBLIC OF KOREA; THAILAND;

MYANMAR; THAILAND;

PLASMODIUM VIVAX;

EID: 78650994376     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.08.011     Document Type: Article

References (34)

1. Alker A.P., Lim P., Sem R., Shah N.K., Yi P., Bouth D.M., Tsuyuoka R., Maguire J.D., Fandeur T., Ariey F., Wongsrichanalai C., Meshnick S.R. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 2007, 76:641-647.
2. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 2004, 48:4075-4083.
3. Baird J.K., Basri H., Purnomo, Bangs M.J., Subianto B., Patchen L.C., Hoffman S.L. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 1991, 44:547-552.
4. Barnadas C., Ratsimbasoa A., Tichit M., Bouchier C., Jahevitra M., Picot S., Menard D. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob. Agents Chemother. 2008, 52:4233-4240.
5. Brega S., Meslin B., de Monbrison F., Severini C., Gradoni L., Udomsangpetch R., Sutanto I., Peyron F., Picot S. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J. Infect. Dis. 2005, 191:272-277.
6. Chotivanich K., Sattabongkot J., Choi Y.K., Park J.S., Sritabal J., Lim C.S., Udomsangpetch R., White N.J., Lee W.J. Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea. Am. J. Trop. Med. Hyg. 2009, 80:902-904.
7. Chotivanich K., Udomsangpetch R., Chierakul W., Newton P.N., Ruangveerayuth R., Pukrittayakamee S., Looareesuwan S., White N.J. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am. J. Trop. Med. Hyg. 2004, 70:395-397.
8. Druilhe P., Brasseur P., Blanc C., Makler M. Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Antimicrob. Agents Chemother. 2007, 51:2112-2116.
9. Dua V.K., Kar P.K., Sharma V.P. Chloroquine resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health 1996, 1:816-819.
10. Fernandez-Becerra C., Pinazo M.J., Gonzalez A., Alonso P.L., del Portillo H.A., Gascon J. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar. J. 2009, 8:55.
11. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naude B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 2000, 6:861-871.
12. Guthmann J.P., Pittet A., Lesage A., Imwong M., Lindegardh N., Min Lwin M., Zaw T., Annerberg A., de Radigues X., Nosten F. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop. Med. Int. Health 2008, 13:91-98.
13. Han E.T., Lee D.H., Park K.D., Seok W.S., Kim Y.S., Tsuboi T., Shin E.H., Chai J.Y. Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea. Korean J. Parasitol. 2006, 44:285-294.
14. Imwong M., Pukrittayakamee S., Pongtavornpinyo W., Nakeesathit S., Nair S., Newton P., Nosten F., Anderson T.J., Dondorp A., Day N.P., White N.J. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob. Agents Chemother. 2008, 52:2657-2659.
15. Kosaisavee V., Suwanarusk R., Nosten F., Kyle D.E., Barrends M., Jones J., Price R., Russell B., Lek-Uthai U. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates. Exp. Parasitol. 2006, 114:34-39.
16. Lee K.S., Kim T.H., Kim E.S., Lim H.S., Yeom J.S., Jun G., Park J.W. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am. J. Trop. Med. Hyg. 2009, 80:215-217.
17. Lim H.S., Im J.S., Cho J.Y., Bae K.S., Klein T.A., Yeom J.S., Kim T.S., Choi J.S., Jang I.J., Park J.W. Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob. Agents Chemother. 2009, 53:1468-1475.
18. Looareesuwan S., Wilairatana P., Krudsood S., Treeprasertsuk S., Singhasivanon P., Bussaratid V., Chokjindachai W., Viriyavejakul P., Chalermrut K., Walsh D.S., White J. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann. Trop. Med. Parasitol. 1999, 93:225-230.
19. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64:97-106.
20. Myat Phone K., Myint O., Myint L., Thaw Z., Kyin Hla A., Nwe Nwe Y. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 1993, 87:687.
21. Nkhoma S., Nair S., Mukaka M., Molyneux M.E., Ward S.A., Anderson T.J. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Trop. 2009, 111:78-81.
22. Nomura T., Carlton J.M., Baird J.K., del Portillo H.A., Fryauff D.J., Rathore D., Fidock D.A., Su X., Collins W.E., McCutchan T.F., Wootton J.C., Wellems T.E. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J. Infect. Dis. 2001, 183:1653-1661.
23. Olliaro P. Drug resistance hampers our capacity to roll back malaria. Clin. Infect. Dis. 2005, 41(Suppl. 4):S247-S257.
24. Plowe C.V., Djimde A., Bouare M., Doumbo O., Wellems T.E. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 1995, 52:565-568.
25. Price R.N., Cassar C., Brockman A., Duraisingh M., van Vugt M., White N.J., Nosten F., Krishna S. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 1999, 43:2943-2949.
26. Rieckmann K.H., Davis D.R., Hutton D.C. Plasmodium vivax resistance to chloroquine?. Lancet 1989, 2:1183-1184.
27. Russell B., Chalfein F., Prasetyorini B., Kenangalem E., Piera K., Suwanarusk R., Brockman A., Prayoga P., Sugiarto P., Cheng Q., Tjitra E., Anstey N.M., Price R.N. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob. Agents Chemother. 2008, 52:1040-1045.
28. Russell B.M., Udomsangpetch R., Rieckmann K.H., Kotecka B.M., Coleman R.E., Sattabongkot J. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. 2003, 47:170-173.
29. Sa J.M., Nomura T., Neves J., Baird J.K., Wellems T.E., del Portillo H.A. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp. Parasitol. 2005, 109:256-259.
30. Snounou G., Singh B. Nested PCR analysis of Plasmodium parasites. Methods Mol. Med. 2002, 72:189-203.
31. Suwanarusk R., Chavchich M., Russell B., Jaidee A., Chalfein F., Barends M., Prasetyorini B., Kenangalem E., Piera K.A., Lek-Uthai U., Anstey N.M., Tjitra E., Nosten F., Cheng Q., Price R.N. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J. Infect. Dis. 2008, 198:1558-1564.
32. Suwanarusk R., Russell B., Chavchich M., Chalfein F., Kenangalem E., Kosaisavee V., Prasetyorini B., Piera K.A., Barends M., Brockman A., Lek-Uthai U., Anstey N.M., Tjitra E., Nosten F., Cheng Q., Price R.N. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One 2007, 2:e1089.
33. Wein S., Maynadier M., Tran Van Ba C., Cerdan R., Peyrottes S., Fraisse L., Vial H. Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J. Clin. Microbiol. 2010, 48:1651-1660.
34. Yeom J.S., Ryu S.H., Oh S., Choi D.H., Song K.J., Oh Y.H., Lee J.H., Kim Y.A., Ahn S.Y., Yang H.Y., Cha J.E., Park J.W. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J. Korean Med. Sci. 2005, 20:707-712.